Breast Cancer Action

Breast Cancer Action (BCAction) is a San Francisco-based grassroots education and advocacy organization founded in 1990 by women living with breast cancer. It emerged from frustration with government agencies and established cancer organizations that, in the founders’ view, were providing inadequate or overly superficial information about the causes and treatment of the disease. The group’s founding perspective treated breast cancer not simply as an individual medical crisis, but as a public-health emergency requiring political action, reliable evidence, prevention, and social change. The organization began with a meeting in founder Elenore Pred’s living room. One of its earliest actions was to meet with the director of the National Cancer Institute and demand a stronger institutional response to the breast-cancer epidemic. After Pred’s death, Susan Claymon became the first breast-cancer activist to address the President’s Cancer Panel in Washington, D.C. These early interventions helped establish BCAction’s characteristic approach: people living with breast cancer should be central participants in health policy, and the disease should be examined in relation to environmental exposure, health-care access, corporate influence, and social inequality. Barbara Brenner became BCAction’s first executive director in 1995 and served until 2010, when she retired because of non-breast-cancer-related health problems. During her tenure, the organization expanded its membership from approximately 3,500 to more than 15,000 and placed greater emphasis on environmental health and criticism of commercialized breast-cancer culture. Brenner became a prominent voice in breast-cancer activism, particularly in challenging the idea that consumer choices alone could prevent the disease or solve the structural problems surrounding it. BCAction’s work has generally centered on three connected areas. The first is screening, diagnosis, and treatment. The organization advocates evidence-based, patient-centered information and argues that screening policies, drug and device approvals, and treatment standards should respond to patients’ needs rather than corporate or industry priorities. It has also supported treatments that are more effective, less toxic, and less costly, while emphasizing meaningful participation in medical decisions. The second area is the prevention of environmental and occupational causes of breast cancer. BCAction argues that many people diagnosed with breast cancer have no clearly identifiable conventional risk factor and that inherited family history explains only a minority of cases. It therefore calls for stronger regulation of potentially hazardous chemicals and for a precautionary approach that reduces involuntary exposure instead of placing responsibility primarily on individuals to shop differently or make supposedly risk-free lifestyle choices. The organization has participated in campaigns concerning chemicals in cosmetics, agricultural pesticides, and recombinant bovine growth hormone in dairy production. The third area is pink-ribbon marketing and culture. BCAction argues that the pink ribbon has helped make breast cancer visible and fostered community, but that it has also become a powerful marketing device operating with insufficient transparency and accountability. Its Think Before You Pink campaign, launched in 2002, encourages consumers to ask where pink-ribbon money goes, how much is donated, what products are being promoted, and whether companies’ business practices are consistent with breast-cancer prevention. The campaign popularized the term and critique of “pinkwashing,” referring to the use of breast-cancer imagery or fundraising claims to improve a company’s public image while obscuring questionable products, practices, or policies. BCAction’s public identity is therefore closer to that of a social-justice and public-health advocacy organization than to a conventional disease-awareness charity. It combines education, grassroots organizing, policy advocacy, environmental-health work, and criticism of corporate fundraising practices. Its stated mission is to pursue health justice for all women at risk of or living with breast cancer, while its analysis also highlights racial, economic, and political inequalities that shape exposure, diagnosis, treatment, and outcomes. Publicly documented accomplishments include contributing to advocacy around California’s Safe Cosmetics Act, efforts that helped drive the removal of recombinant bovine growth hormone from some dairy products, and opposition to the agricultural fumigant methyl iodide, which was subsequently withdrawn from the California market by its manufacturer. Current organizational details beyond the supplied reference material should be verified against the official website.

Breast Cancer Action was formed in 1990 by Elenore Pred, Susan Claymon, Belle Shayer, Linda Reyes, and other women living with breast cancer in the San Francisco Bay Area. The founders were seeking dependable information about breast-cancer causes and treatment but encountered what they regarded as inadequate responses from government bodies and private organizations. Their first organizing meeting took place in Pred’s living room, where they articulated a dual purpose of education and political action aimed at preventing a further rise in breast cancer. The new organization quickly adopted a systemic view of the disease. Rather than framing breast cancer solely as a matter of individual behavior or personal treatment decisions, its founders argued that government research priorities, environmental exposures, health-care institutions, and corporate interests all influenced the epidemic. One early delegation met with the director of the National Cancer Institute to demand greater attention to breast cancer. Following Pred’s death, Susan Claymon continued this public advocacy by becoming the first breast-cancer activist to address the President’s Cancer Panel. Barbara Brenner became the organization’s first executive director in 1995. She remained in the role until 2010, retiring because of health issues unrelated to breast cancer. During her leadership, BCAction’s membership grew from roughly 3,500 to more than 15,000. The organization also developed a stronger environmental-health program and more directly criticized the commercialization of breast-cancer activism. Brenner’s tenure helped establish BCAction as a national voice for activists who believed that awareness campaigns should be matched by prevention, accountability, and policy change. BCAction’s advocacy subsequently developed around three broad priorities. In screening, diagnosis, and treatment, it has promoted evidence-based and patient-centered information, greater access to care, and therapies that are effective, less toxic, and less expensive. It has also examined the influence of corporate interests on research, medical devices, drug approvals, screening recommendations, and treatment decisions. The organization’s approach places the experiences and needs of patients at the center of health policy rather than treating them as secondary to institutional or commercial priorities. Environmental prevention became another central part of the organization’s work. BCAction has argued that the absence of an obvious personal or inherited risk factor does not mean that breast cancer is unavoidable or purely random. It has emphasized research on toxic chemicals and the possibility that cumulative exposure contributes to disease risk. Its policy position favors precautionary public-health measures and the elimination or reduction of involuntary exposure, rather than relying on individuals to purchase supposedly safer products or make isolated lifestyle changes. In 2002, BCAction launched Think Before You Pink, its best-known campaign. The campaign questions the accountability and transparency of pink-ribbon promotions, asking consumers to determine how much money a promotion raises, which organization receives it, whether there is a donation cap, and whether the promoted product or company’s practices conflict with breast-cancer prevention. BCAction uses the campaign to criticize “pinkwashing,” a term for marketing that invokes breast cancer to create goodwill without addressing potentially harmful products, environmental exposures, or structural inequalities. The organization has participated in several environmental and consumer campaigns. Advocacy connected with a two-year effort helped support California’s Safe Cosmetics Act of 2005, which increased scrutiny of cosmetic safety. In 2009, campaigns concerning recombinant bovine growth hormone helped generate pressure on dairy companies, including General Mills and Dannon, and the hormone was removed from relevant products. In 2011, BCAction joined Pesticide Action Network in opposing methyl iodide as an agricultural fumigant in California. A legal challenge and public criticism focused on potential risks to workers, communities, children, and unborn fetuses. The manufacturer later withdrew the fumigant and requested cancellation of its California registration. BCAction’s historical significance lies in its combination of breast-cancer patient advocacy, environmental-health activism, and criticism of disease commercialization. It has consistently presented breast cancer as a public-health and health-justice issue shaped by social, economic, political, racial, and environmental conditions. The organization is based in San Francisco and has operated primarily through education, organizing, policy advocacy, and public campaigns. Details about its present leadership, programs, and operational status should be confirmed through current official materials.

• 2011

  Methyl iodide is withdrawn from the California market

  [1]Breast Cancer Actionen.wikipedia.org

  BCAction and allied organizations campaign against methyl iodide use as an agricultural fumigant; the manufacturer later withdraws the product and seeks cancellation of its state registration.

• 2010

  Barbara Brenner retires as executive director

  [1]Breast Cancer Actionen.wikipedia.org

  Brenner leaves the executive-director role because of non-breast-cancer-related health issues after leading the organization for approximately fifteen years.

• 2009

  Campaigns address recombinant bovine growth hormone

  [1]Breast Cancer Actionen.wikipedia.org

  Awareness efforts help pressure major dairy companies to remove recombinant bovine growth hormone from relevant products.

• 2005

  California Safe Cosmetics Act is enacted

  [1]Breast Cancer Actionen.wikipedia.org

  A two-year awareness campaign contributes to support for California legislation increasing scrutiny of cosmetic ingredients and safety.

• 2002

  Think Before You Pink launches

  [1]Breast Cancer Actionen.wikipedia.org

  BCAction begins its signature campaign challenging opaque pink-ribbon fundraising and corporate pinkwashing.

• 1995

  Barbara Brenner becomes executive director

  [1]Breast Cancer Actionen.wikipedia.org

  Brenner begins a leadership period associated with membership growth and a stronger focus on environmental health and the politics of breast-cancer activism.

• 1990

  Breast Cancer Action is founded

  [1]Breast Cancer Actionen.wikipedia.org

  Women living with breast cancer in the San Francisco Bay Area establish the organization to provide better information and pursue political action against the disease.

A grassroots, patient-centered and social-justice-oriented breast-cancer advocacy organization that emphasizes systemic prevention, health equity, environmental accountability, and scrutiny of corporate pink-ribbon marketing rather than consumer-focused awareness alone.

• Consumer advocacy campaign · 2002

  Think Before You Pink

  BCAction’s signature campaign examines the claims and practices behind pink-ribbon promotions. It encourages consumers to ask how much money a promotion actually raises, where the funds go, whether donations are capped, and whether a company’s products or policies are compatible with breast-cancer prevention. The campaign is also a major public vehicle for BCAction’s critique of pinkwashing and the commercialization of breast-cancer awareness.

• Health advocacy resources

  Breast-cancer education and treatment analysis

  BCAction produces educational and advocacy material concerning breast-cancer screening, diagnosis, treatment, health-care access, drug and device approval, and patient participation in medical decisions. Its perspective emphasizes evidence, patient needs, reduced toxicity, affordability, and independence from commercial bias.

• Environmental-health advocacy

  Environmental breast-cancer prevention advocacy

  This body of work addresses involuntary exposure to potentially hazardous chemicals and challenges the idea that individual purchasing decisions are sufficient prevention. BCAction advocates precautionary, population-level policies concerning chemicals in consumer products, cosmetics, agriculture, and other areas of daily life.

• 2011Methyl iodide opposition

  California, United States

  BCAction joined Pesticide Action Network in opposing the approval and use of methyl iodide as an agricultural fumigant, citing concerns about toxic exposure and risks to vulnerable populations.

  Outcome. The manufacturer withdrew the fumigant and requested cancellation of its California registration after litigation and public opposition.

  Source
• 2009rBGH/rBST dairy advocacy

  United States

  BCAction and allied advocates raised public awareness about recombinant bovine growth hormone in dairy products, including criticism associated with Yoplait’s fundraising promotion.

  Outcome. General Mills and Dannon removed recombinant bovine growth hormone from relevant dairy products after public and market pressure.

  Source
• 2003California Safe Cosmetics advocacy

  California, United States

  BCAction participated in a two-year awareness and advocacy effort focused on scrutiny of potentially hazardous chemicals in cosmetics.

  Outcome. The California Safe Cosmetics Act was signed in 2005, increasing state attention to cosmetic ingredient safety.

  Source
• 2002Think Before You Pink

  United States

  The campaign asks consumers and companies to scrutinize pink-ribbon promotions, donation terms, product safety, and corporate accountability. It challenges the use of breast-cancer imagery to generate goodwill without meaningful action on prevention or health justice.

  Outcome. The campaign became BCAction’s best-known public initiative and a prominent critique of pinkwashing and commercialized breast-cancer culture.

  Source

• 2011

  Oppose methyl iodide registrationOther

  Background

  The organization and allied scientists and advocates raised concerns that methyl iodide fumigation could expose workers, communities, children, and unborn fetuses to significant toxic risks.

  Action taken

  BCAction joined Pesticide Action Network in public advocacy and litigation challenging California’s approval of the fumigant.

  Aftermath

  The manufacturer withdrew the product and asked California regulators to cancel its registration, citing lack of market viability.

  Source

• 2005

  Support stronger cosmetic-safety oversightOther

  Background

  BCAction connected potential environmental causes of breast cancer with the presence of chemicals in consumer products and cosmetics.

  Action taken

  It participated in a two-year awareness campaign supporting California legislation on cosmetic ingredient safety.

  Aftermath

  The California Safe Cosmetics Act was enacted after being signed by Governor Arnold Schwarzenegger.

  Source

• 2002

  Challenge pink-ribbon marketing through Think Before You PinkStrategy

  Background

  BCAction viewed the growing use of the pink ribbon as a marketing tool as insufficiently transparent and potentially disconnected from genuine breast-cancer prevention.

  Action taken

  The organization launched a consumer-education and accountability campaign focused on donation terms, corporate practices, product safety, and pinkwashing.

  Aftermath

  Think Before You Pink became the organization’s most recognizable campaign and shaped public discussion about the commercialization of breast-cancer awareness.

  Source

1. 1Breast Cancer Actionen.wikipedia.org
2. 2Breast Cancer Action official websitebcaction.org